Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Annals of Neurology|December 1, 1986
Vasopressin in Alzheimer's disease: a study of postmortem brain concentrationsM F Mazurek, M F Beal, E D Bird, et al.The Journal of Clinical Psychiatry|September 1, 1990
Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepamP I Rosebush, A M Hildebrand, B G Furlong, et al.Brain Research|March 15, 2011
Role of the dopamine transporter in mediating the neuroleptic-induced reduction of tyrosine hydroxylase-immunoreactive midbrain neuronsK B Reynolds, L MacGillivray, M Zettler, et al.Synapse (New York, N.Y.)|May 18, 2011
Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigraL MacGillivray, K B Reynolds, M Sickand, et al.Annals of Neurology|October 1, 1992
The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortexE Storey, N W Kowall, S F Finn, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1998
Persistent loss of tyrosine hydroxylase immunoreactivity in the substantia nigra after neuroleptic withdrawalM F Mazurek, S M Savedia, R S Bobba, et al.Translational Psychiatry|November 15, 2012
Psychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disordersR E Anglin, P I Rosebush, M D Noseworthy, et al.Neuroscience|September 28, 2010
Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificityL MacGillivray, L M Lagrou, K B Reynolds, et al.Journal of Neurochemistry|February 1, 1986
Somatostatin binding sites in human and monkey brain: localization and characterizationM F Beal, V T Tran, M F Mazurek, et al.Brain Research|March 19, 1986
Somatostatin-28(1-12)-like immunoreactivity is reduced in Alzheimer's disease cerebral cortexM F Beal, R Benoit, M F Mazurek, et al.Pageof 6